SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 51.68 |
| Enterprise Value ($M) | 28.63 |
| Book Value ($M) | -1.64 |
| Book Value / Share | -0.06 |
| Price / Book | -31.44 |
| NCAV ($M) | -55.50 |
| NCAV / Share | -1.88 |
| Price / NCAV | -0.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.62 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.06 |
| Current Ratio | 1.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 90.37 |
| Assets | 144.22 |
| Liabilities | 145.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 57.67 |
| Operating Income | -103.00 |
| Net Income | -46.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -80.19 |
| Cash from Investing | -15.00 |
| Cash from Financing | 70.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.00 | ||
| 13D/A | Rosenwald Lindsay A Md | 18.40 | 85.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 31,169 | 122,547 | 25.43 | |
| 51,880 | 132,566 | 39.14 | |
| 32,967 | 64,034 | 51.48 | |
| 21,413 | 66,620 | 32.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ESLA – Estrella Immunopharma, Inc. | EVOK – Evoke Pharma, Inc. |
| EYEN – Eyenovia, Inc. | FBLG – FibroBiologics, Inc. |
| FBRX – Forte Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io